Nicholas Brian Shannon, Narayanan Gopalakrishna lyer, Melvin Lee Kiang Chua
{"title":"利用人工智能和放射组学改善鼻咽癌预后","authors":"Nicholas Brian Shannon, Narayanan Gopalakrishna lyer, Melvin Lee Kiang Chua","doi":"10.1002/cam4.70706","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Introduction</h3>\n \n <p>Nasopharyngeal carcinoma (NPC) typically presents as advanced disease due to the lack of significant symptoms in the early stages. Accurate prognostication is therefore challenging as current methods based on anatomical staging often lack the granularity to differentiate between patients with differing prognoses. This study investigates the potential of radiomics to improve the prediction of locoregional recurrence (LRR) and overall survival in patients with NPC.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Radiomic features were extracted from radiotherapy planning CT scans for 294 NPC patients divided into training (<i>n</i> = 147) and validation (<i>n</i> = 147) sets. A feature selection step utilising feature clustering and mutual information classifier to select six key radiomic features was employed to reduce redundancy and improve interpretability. Models were trained using clinical data, radiomic features, and these in combination to predict 2-year LRR, with performance assessed on the left-out independent validation set.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Combining radiomic features with clinical data resulted in the best performance for predicting 2-year LRR (Area Under the Curve, AUC 0.76) compared to prediction using clinical or radiomic features alone (mean AUC 0.56 and 0.57, respectively). Risk stratification based on the combined model was significant for LRR-free survival and overall survival (<i>p</i> < 0.01). Key radiomic features included tumour size, intensity distribution, overall textural patterns, and distribution of fine and coarse textured regions.</p>\n </section>\n \n <section>\n \n <h3> Discussion</h3>\n \n <p>Radiomics holds promise for improving NPC risk stratification, potentially allowing for personalised treatment strategies. The most important radiomics feature, maximum 2D diameter, suggests a need to reconsider tumour size as a prognostic criterion despite its current exclusion from TNM staging. Larger prospective studies are needed to validate these findings.</p>\n </section>\n </div>","PeriodicalId":139,"journal":{"name":"Cancer Medicine","volume":"14 6","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cam4.70706","citationCount":"0","resultStr":"{\"title\":\"Leveraging Artificial Intelligence and Radiomics for Improved Nasopharyngeal Carcinoma Prognostication\",\"authors\":\"Nicholas Brian Shannon, Narayanan Gopalakrishna lyer, Melvin Lee Kiang Chua\",\"doi\":\"10.1002/cam4.70706\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Introduction</h3>\\n \\n <p>Nasopharyngeal carcinoma (NPC) typically presents as advanced disease due to the lack of significant symptoms in the early stages. Accurate prognostication is therefore challenging as current methods based on anatomical staging often lack the granularity to differentiate between patients with differing prognoses. This study investigates the potential of radiomics to improve the prediction of locoregional recurrence (LRR) and overall survival in patients with NPC.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>Radiomic features were extracted from radiotherapy planning CT scans for 294 NPC patients divided into training (<i>n</i> = 147) and validation (<i>n</i> = 147) sets. A feature selection step utilising feature clustering and mutual information classifier to select six key radiomic features was employed to reduce redundancy and improve interpretability. Models were trained using clinical data, radiomic features, and these in combination to predict 2-year LRR, with performance assessed on the left-out independent validation set.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>Combining radiomic features with clinical data resulted in the best performance for predicting 2-year LRR (Area Under the Curve, AUC 0.76) compared to prediction using clinical or radiomic features alone (mean AUC 0.56 and 0.57, respectively). Risk stratification based on the combined model was significant for LRR-free survival and overall survival (<i>p</i> < 0.01). Key radiomic features included tumour size, intensity distribution, overall textural patterns, and distribution of fine and coarse textured regions.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Discussion</h3>\\n \\n <p>Radiomics holds promise for improving NPC risk stratification, potentially allowing for personalised treatment strategies. The most important radiomics feature, maximum 2D diameter, suggests a need to reconsider tumour size as a prognostic criterion despite its current exclusion from TNM staging. Larger prospective studies are needed to validate these findings.</p>\\n </section>\\n </div>\",\"PeriodicalId\":139,\"journal\":{\"name\":\"Cancer Medicine\",\"volume\":\"14 6\",\"pages\":\"\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-03-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cam4.70706\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/cam4.70706\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cam4.70706","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
Leveraging Artificial Intelligence and Radiomics for Improved Nasopharyngeal Carcinoma Prognostication
Introduction
Nasopharyngeal carcinoma (NPC) typically presents as advanced disease due to the lack of significant symptoms in the early stages. Accurate prognostication is therefore challenging as current methods based on anatomical staging often lack the granularity to differentiate between patients with differing prognoses. This study investigates the potential of radiomics to improve the prediction of locoregional recurrence (LRR) and overall survival in patients with NPC.
Methods
Radiomic features were extracted from radiotherapy planning CT scans for 294 NPC patients divided into training (n = 147) and validation (n = 147) sets. A feature selection step utilising feature clustering and mutual information classifier to select six key radiomic features was employed to reduce redundancy and improve interpretability. Models were trained using clinical data, radiomic features, and these in combination to predict 2-year LRR, with performance assessed on the left-out independent validation set.
Results
Combining radiomic features with clinical data resulted in the best performance for predicting 2-year LRR (Area Under the Curve, AUC 0.76) compared to prediction using clinical or radiomic features alone (mean AUC 0.56 and 0.57, respectively). Risk stratification based on the combined model was significant for LRR-free survival and overall survival (p < 0.01). Key radiomic features included tumour size, intensity distribution, overall textural patterns, and distribution of fine and coarse textured regions.
Discussion
Radiomics holds promise for improving NPC risk stratification, potentially allowing for personalised treatment strategies. The most important radiomics feature, maximum 2D diameter, suggests a need to reconsider tumour size as a prognostic criterion despite its current exclusion from TNM staging. Larger prospective studies are needed to validate these findings.
期刊介绍:
Cancer Medicine is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research from global biomedical researchers across the cancer sciences. The journal will consider submissions from all oncologic specialties, including, but not limited to, the following areas:
Clinical Cancer Research
Translational research ∙ clinical trials ∙ chemotherapy ∙ radiation therapy ∙ surgical therapy ∙ clinical observations ∙ clinical guidelines ∙ genetic consultation ∙ ethical considerations
Cancer Biology:
Molecular biology ∙ cellular biology ∙ molecular genetics ∙ genomics ∙ immunology ∙ epigenetics ∙ metabolic studies ∙ proteomics ∙ cytopathology ∙ carcinogenesis ∙ drug discovery and delivery.
Cancer Prevention:
Behavioral science ∙ psychosocial studies ∙ screening ∙ nutrition ∙ epidemiology and prevention ∙ community outreach.
Bioinformatics:
Gene expressions profiles ∙ gene regulation networks ∙ genome bioinformatics ∙ pathwayanalysis ∙ prognostic biomarkers.
Cancer Medicine publishes original research articles, systematic reviews, meta-analyses, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented in the paper.